Isto Biologics is listed on the portfolio pages of Keensight Capital (portfolio page) and Thompson Street Capital Partners (portfolio page). Keensight Capital and Thompson Street Capital Partners list it as current.
Isto Biologics is a Life Sciences & Healthcare company. Its owner on record, Keensight Capital, is a growth buyout firm. Keensight Capital lists 56 companies in the index, 3 of them in Life Sciences & Healthcare. Also backed by Thompson Street Capital Partners.
Keensight Capital is a European Growth Buyout investor focusing on fast growing and profitable companies in the Technology and Healthcare sectors.
Read the Keensight Capital profileThompson Street Capital Partners invests in middle-market businesses within the life sciences, healthcare, software, technology, and business and consumer services sectors.
Read the Thompson Street Capital Partners profileIsto Biologics, a Thompson Street Capital Partners portfolio company, acquired NovaBone
keensight.comIsto Biologics is listed on the portfolio pages of Keensight Capital (portfolio page) and Thompson Street Capital Partners (portfolio page). Keensight Capital and Thompson Street Capital Partners list it as current.
Isto Biologics is in Life Sciences & Healthcare. Classified from the owner's portfolio label.
Keensight Capital lists 2 other Life Sciences & Healthcare companies in the index, including Paradigm and Unither Pharmaceuticals.
6 of 55 shown
See the full Keensight Capital portfolio.
6 of 67 shown
See the full Thompson Street Capital Partners portfolio.
Browse PE-backed companies.
